Advertisement

Pneumococcal vaccine protects children from otitis

The frequent ear infections suffered by some infants during the first two years of life can be difficult to treat. Most are caused by Streptococcus pneumoniae, also responsible for chest infections in adults and for which there is already a vaccine. A team from the National Public Health Institute, Helsinki, Finland tested the efficacy of the new conjugate pneumococcal vaccine in children and found that it can also be effective in the prevention of ear infections (N Engl J Med 2001, 344:403-409)

By | February 13, 2001

The frequent ear infections suffered by some infants during the first two years of life can be difficult to treat. Most are caused by Streptococcus pneumoniae, also responsible for chest infections in adults and for which there is already a vaccine. A team from the National Public Health Institute, Helsinki, Finland tested the efficacy of the new conjugate pneumococcal vaccine in children and found that it can also be effective in the prevention of ear infections (N Engl J Med 2001, 344:403-409).

Juhani Eskola and colleagues investigated 1662 infants in a randomised, double-blind trial of the heptavalent pneumococcal polysaccharide conjugate vaccine CRM197. The children received either the pneumococcal vaccine or a hepatitis B vaccine as a control at 2, 4, 6 and 12 months of age; they were followed up until the age of two years.

The vaccine reduced by 57% the number of episodes of acute otitis media caused by the serotypes included in it. The number of otitis episodes attributed to serotypes that are cross-reactive with those in the vaccine was reduced by 51%. But the number of episodes due to all other serotypes increased by 33%.

Advertisement
Advertisement
BD Biosciences
BD Biosciences

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Simulating Scientific Sabotage, For Fun
  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Advertisement
Life Technologies